New Delhi: Kanishka Biswas, an affiliate professor on the Jawaharlal Nehru Centre for Superior Scientific Analysis (JNCASR), has obtained the celebrated Shanti Swarup Bhatnagar Prize in Chemical Science for his discoveries within the area of solid-state inorganic chemistry and thermoelectric vitality conversion.
JNCASR is an autonomous institute of the Division of Science and Know-how beneath the federal government of India.
“Biswas’ analysis includes a basic understanding of the connection between construction and property of inorganic solids to develop lead (Pb)-free high-performance thermoelectric supplies, which might effectively convert waste warmth to vitality and are being translated into cost-effective applied sciences,” a launch from the Ministry of Science and Know-how mentioned on Monday.
Utilizing basic and insightful chemical rules, Biswas has achieved thermoelectric efficiency by way of management of atomic ordering and consequent digital state delocalisation in a crystalline inorganic stable, concurrently enhancing its digital transport and lowering the thermal conductivity, which was revealed within the ‘Science’ journal this yr.
His progressive methods to tune the thermoelectric properties with chemical bonding hierarchy, ferroelectric instability, and rattling atoms in a category of chemical compounds referred to as steel chalcogenides have superior the frontiers of inorganic solid-state chemistry introducing new paradigms.
Biswas, who hails from Habra close to Kolkata, studied chemistry on the Jadavpur College earlier than doing his PhD from the Indian Institute of Science (IISc), Bengaluru.
In the meantime, Jeemon Panniyammakal, at the moment positioned as an assistant professor on the Sree Chitra Tirunal Institute for Medical Sciences and Know-how (SCTIMST), Trivandrum, is among the 11 recipients of the Shanti Swarup Bhatnagar Prize for Science and Know-how for his exemplary analysis work and management within the area of continual illness epidemiology, complicated public well being interventions and high quality enchancment initiatives.
SCTIMST an autonomous institute beneath the Division of Science and Know-how.
Jeemon’s contributions to the task-sharing mannequin for administration of hypertension and diabetes in group settings have been extensively appreciated within the tutorial group and policymakers within the low and middle-income nations.
Two necessary analysis papers primarily based on this work have been revealed not too long ago within the Lancet World Well being journal.
Jeemon, who hails from Nilambur, Kerala, refined his analysis abilities whereas working with eminent cardiologists like Okay. Srinath Reddy and D. Prabhakaran, previously related to the division of cardiology, AIIMS New Delhi.
Equally, T Govindaraju from JNCASR has obtained the celebrated Shanti Swarup Bhatnagar Prize for Science and Know-how.
He obtained the prize for his ground-breaking ideas and discoveries, which have vital potential for prognosis and therapy for Alzheimer’s, lung most cancers amongst different well being issues. His progressive work on small molecules, peptides, and pure merchandise presents each diagnostics in addition to therapeutics, resulting in personalised medication, a launch from the Ministry of S&T mentioned.
After finishing PhD from CSIR-NCL and post-doctoral fellowship in main analysis institutes in USA and Germany, Professor Govindaraju’s analysis focussed on bioorganic and chemical biology is addressing unresolved issues associated to human well being – neuro-degenerative ailments in addition to most cancers.
His persistent analysis efforts during the last 10 years paid off earlier this yr. He has found a novel drug candidate molecule (TGR63), which successfully reduces the burden of poisonous protein aggregation species referred to as amyloid within the mind affected by Alzheimer’s illness and reverses cognitive decline in animal fashions. A pharmaceutical firm has picked this molecule for medical trials, which reveals wonderful promise to deal with Alzheimer’s illness in people.
His curiosity in understanding the connection between Alzheimer’s illness and most cancers resulted within the discovery of the primary small molecule-based drug candidate (TGP18) for lung most cancers, one of many tough sorts for early detection and therapy. Fascinatingly, this molecule may also perform as a diagnostic device and is among the few molecules globally to be labeled as “theragnostic” (diagnostic remedy) candidate.